Abel Ang retires as Group Chief Executive Officer after a decade and will continue to serve on the Board of Directors Achieved record global revenues of US$335.0 million, a 15.1% increase ...
Integrated urology leader Advanced MedTech Holdings (AMTH or the Group) announced the acquisition of a majority interest in WIKKON, the Chinese market leader in urology and shock wave therapy devices.
Temasek Holdings is exploring selling Advanced MedTech, multiple sources told Reuters on Monday, after the medical devices firm, fully-owned by the Singaporean state investor, received interest from ...
-- The new name signifies the group's sharpened focus on urology leadership globally -- Rebranding follows the company's recent spin out from Accuron Technologies to be wholly owned by Temasek ...
Dublin, April 15, 2021 (GLOBE NEWSWIRE) -- The "Innovations and Growth Opportunities in Medical Packaging Solutions, Digital Health, Advanced Implantables, and Diagnostic Solutions" report has been ...
Advanced Scanners Inc., a company using light to enable the next generation of digital surgery, has named Douglas Fairbanks their new Chief Operating Officer. Fairbanks joins the executive team as the ...
VALENCIA, Calif.--(BUSINESS WIRE)--Advanced Bionics (AB) announces that their patented HiRes™ Ultra 3D Cochlear Implant has been awarded the MedTech Breakthrough Award 2019 for Best Overall Medical ...
Achieved record global revenues of US$335.0 million, a 15.1% increase year-over-year driven by strong performances in all segments United States entities grew revenue by 22.3%, making up 55.4% of ...
Acquisition expands Advanced MedTech’s urological market access in China via a comprehensive nationwide sales & service network and an established local R&D, manufacturing & supply chain ecosystem ...
SINGAPORE, Nov 14 (Reuters) - Temasek Holdings is exploring selling Advanced MedTech, multiple sources told Reuters on Monday, after the medical devices firm, fully-owned by the Singaporean state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback